Clinical studies have demonstrated that intermittent administration of PTH(1–34) mediates osteoanabolic effects through increased proliferation and differentiation of osteoblasts [6], and PTH or its biological N-terminal fragment PTH(1–34) is currently in use as a therapy for osteoporosis. Here, PTH is linked to osteoporosis.